In vitro system for evaluation of the immunomodulatory capacity of CD45(R) reagents.
Poppema
S
S
Department of Pathology, University of Groningen, The Netherlands.
Visser
L
L
Jiang
X Y
XY
D000906:Antibodies / Q000494:pharmacology*; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D015703:Antigens, CD / Q000096:biosynthesis / Q000276:immunology*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000096:biosynthesis; D002478:Cells, Cultured; D005434:Flow Cytometry; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D037181:Lectins, C-Type; D017493:Leukocyte Common Antigens / Q000096:biosynthesis / Q000276:immunology*; D008213:Lymphocyte Activation; D016853:Muromonab-CD3 / Q000494:pharmacology; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis; D013601:T-Lymphocytes / Q000276:immunology*; D000099192:CD69 Antigens
D000906:Antibodies; D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D007166:Immunosuppressive Agents; D037181:Lectins, C-Type; D017493:Leukocyte Common Antigens; D016853:Muromonab-CD3; D015375:Receptors, Interleukin-2; D000099192:CD69 Antigens